Library / Laws / 113th / hr / H.R. 4302 / rds
II
113th CONGRESS
2d Session
H. R. 4302
IN THE SENATE OF THE UNITED STATES
March 27, 2014Received
AN ACT
To amend the Social Security Act to extend Medicare payments to physicians and other provisions of
the Medicare and Medicaid programs, and for other purposes.
1.
Short title; table of contents
(a)
Short title
This Act may be cited as the Protecting Access to Medicare Act of 2014.
(b)
Table of contents
The table of contents of this Act is as follows:
Sec. 1. Short title; table of contents.
Title I—Medicare Extenders
Sec. 101. Physician payment update.
Sec. 102. Extension of work GPCI floor.
Sec. 103. Extension of therapy cap exceptions process.
Sec. 104. Extension of ambulance add-ons.
Sec. 105. Extension of increased inpatient hospital payment adjustment for certain low-volume
hospitals.
Sec. 106. Extension of the Medicare-dependent hospital (MDH) program.
Sec. 107. Extension for specialized Medicare Advantage plans for special needs individuals.
Sec. 108. Extension of Medicare reasonable cost contracts.
Sec. 109. Extension of funding for quality measure endorsement, input, and selection.
Sec. 110. Extension of funding outreach and assistance for low-income programs.
Sec. 111. Extension of two-midnight rule.
Sec. 112. Technical changes to Medicare LTCH amendments.
Title II—Other Health Provisions
Sec. 201. Extension of the qualifying individual (QI) program.
Sec. 202. Temporary extension of transitional medical assistance (TMA).
Sec. 203. Extension of Medicaid and CHIP express lane option.
Sec. 204. Extension of special diabetes program for type I diabetes and for Indians.
Sec. 205. Extension of abstinence education.
Sec. 206. Extension of personal responsibility education program (PREP).
Sec. 207. Extension of funding for family-to-family health information centers.
Sec. 208. Extension of health workforce demonstration project for low-income individuals.
Sec. 209. Extension of maternal, infant, and early childhood home visiting programs.
Sec. 210. Pediatric quality measures.
Sec. 211. Delay of effective date for Medicaid amendments relating to beneficiary liability
settlements.
Sec. 212. Delay in transition from ICD–9 TO ICD–10 code sets.
Sec. 213. Elimination of limitation on deductibles for employer-sponsored health plans.
Sec. 214. GAO report on the Children’s Hospital Graduate Medical Education Program.
Sec. 215. Skilled nursing facility value-based purchasing.
Sec. 216. Improving Medicare policies for clinical diagnostic laboratory tests.
Sec. 217. Revisions under the Medicare ESRD prospective payment system.
Sec. 218. Quality incentives for computed tomography diagnostic imaging and promoting
evidence-based care.
Sec. 219. Using funding from Transitional Fund for Sustainable Growth Rate (SGR) Reform.
Sec. 220. Ensuring accurate valuation of services under the physician fee schedule.
Sec. 221. Medicaid DSH.
Sec. 222. Realignment of the Medicare sequester for fiscal year 2024.
Sec. 223. Demonstration programs to improve community mental health services.
Sec. 224. Assisted outpatient treatment grant program for individuals with serious mental illness.
Sec. 225. Exclusion from PAYGO scorecards.
I
Medicare Extenders
101.
Physician payment update
Section 1848(d) of the Social Security Act (42 U.S.C. 1395w–4(d)) is amended—
(1) in paragraph (15)—
(A) in the heading, by striking January through March of;
(B) in subparagraph (A), by striking for the period beginning on January 1, 2014, and ending on March 31, 2014; and
(C) in subparagraph (B)—
(i) in the heading, by striking remaining portion of 2014 and; and
(ii) by striking the period beginning on April 1, 2014, and ending on December 31, 2014, and for; and
(2) by adding at the end the following new paragraph:
(16)
Update for January through March of 2015
(A)
In general
Subject to paragraphs (7)(B), (8)(B), (9)(B), (10)(B), (11)(B), (12)(B), (13)(B), (14)(B), and
(15)(B), in lieu of the update to the single conversion factor established
in paragraph (1)(C) that would otherwise apply for 2015 for the period
beginning on January 1, 2015, and ending on March 31, 2015, the update to
the single conversion factor shall be 0.0 percent.
(B)
No effect on computation of conversion factor for remaining portion of 2015 and subsequent years
The conversion factor under this subsection shall be computed under paragraph (1)(A) for the period
beginning on April 1, 2015, and ending on December 31, 2015, and for 2016
and subsequent years as if subparagraph (A) had never applied.
.
102.
Extension of work GPCI floor
Section 1848(e)(1)(E) of the Social Security Act (42 U.S.C. 1395w–4(e)(1)(E)) is amended by striking April 1, 2014 and inserting April 1, 2015.
103.
Extension of therapy cap exceptions process
Section 1833(g) of the Social Security Act (42 U.S.C. 1395l(g)) is amended—
(1) in paragraph (5)(A), in the first sentence, by striking March 31, 2014 and inserting March 31, 2015; and
(2) in paragraph (6)(A)—
(A) by striking March 31, 2014 and inserting March 31, 2015; and
(B) by striking 2012, 2013, or the first three months of 2014 and inserting 2012, 2013, 2014, or the first three months of 2015.
104.
Extension of ambulance add-ons
(a)
Ground Ambulance
Section 1834(l)(13)(A) of the Social Security Act (42 U.S.C. 1395m(l)(13)(A)) is amended by striking April 1, 2014 and inserting April 1, 2015 each place it appears.
(b)
Super rural ground ambulance
Section 1834(l)(12)(A) of the Social Security Act (42 U.S.C. 1395m(l)(12)(A)) is amended, in the first sentence, by striking April 1, 2014 and inserting April 1, 2015.
105.
Extension of increased inpatient hospital payment adjustment for certain low-volume hospitals
Section 1886(d)(12) of the Social Security Act (42 U.S.C. 1395ww(d)(12)) is amended—
(1) in subparagraph (B), in the matter preceding clause (i), by striking in the portion of fiscal year 2014 beginning on April 1, 2014, fiscal year 2015, and subsequent
fiscal years and inserting in fiscal year 2015 (beginning on April 1, 2015), fiscal year 2016, and subsequent fiscal years;
(2) in subparagraph (C)(i), by striking fiscal years 2011, 2012, and 2013, and the portion of fiscal year 2014 before and inserting fiscal years 2011 through 2014 and fiscal year 2015 (before April 1, 2015), each place it appears; and
(3) in subparagraph (D), by striking fiscal years 2011, 2012, and 2013, and the portion of fiscal year 2014 before April 1, 2014, and inserting fiscal years 2011 through 2014 and fiscal year 2015 (before April 1, 2015),.
106.
Extension of the Medicare-dependent hospital (MDH) program
(a)
In general
Section 1886(d)(5)(G) of the Social Security Act (42 U.S.C. 1395ww(d)(5)(G)) is amended—
(1) in clause (i), by striking April 1, 2014 and inserting April 1, 2015; and
(2) in clause (ii)(II), by striking April 1, 2014 and inserting April 1, 2015.
(b)
Conforming amendments
(1)
Extension of target amount
Section 1886(b)(3)(D) of the Social Security Act (42 U.S.C. 1395ww(b)(3)(D)) is amended—
(A) in the matter preceding clause (i), by striking April 1, 2014 and inserting April 1, 2015; and
(B) in clause (iv), by striking through fiscal year 2013 and the portion of fiscal year 2014 before April 1, 2014 and inserting through fiscal year 2014 and the portion of fiscal year 2015 before April 1, 2015.
(2)
Permitting hospitals to decline reclassification
Section 13501(e)(2) of the Omnibus Budget Reconciliation Act of 1993 (42 U.S.C. 1395ww note) is amended by striking through the first 2 quarters of fiscal year 2014 and inserting through the first 2 quarters of fiscal year 2015.
107.
Extension for specialized Medicare Advantage plans for special needs individuals
Section 1859(f)(1) of the Social Security Act (42 U.S.C. 1395w–28(f)(1)) is amended by striking 2016 and inserting 2017.
108.
Extension of Medicare reasonable cost contracts
Section 1876(h)(5)(C)(ii) of the Social Security Act (42 U.S.C. 1395mm(h)(5)(C)(ii)) is amended, in the matter preceding subclause (I), by striking January 1, 2015 and inserting January 1, 2016.
109.
Extension of funding for quality measure endorsement, input, and selection
Section 1890(d) of the Social Security Act (42 U.S.C. 1395aaa(d)) is amended—
(1) by inserting (1) before For purposes; and
(2) by adding at the end the following new paragraph:
(2) For purposes of carrying out this section and section 1890A (other than subsections (e) and (f)),
the Secretary shall provide for the transfer, from the Federal Hospital
Insurance Trust Fund under section 1817 and the Federal Supplementary
Medical Insurance Trust Fund under section 1841, in such proportion as the
Secretary determines appropriate, to the Centers for Medicare & Medicaid Services Program Management Account of $5,000,000 for fiscal year 2014 and $15,000,000
for the first 6 months of fiscal year 2015. Amounts transferred under the
preceding sentence shall remain available until expended.
.
110.
Extension of funding outreach and assistance for low-income programs
(a)
Additional funding for state health insurance programs
Subsection (a)(1)(B) of section 119 of the Medicare Improvements for Patients and Providers Act of
2008 (42 U.S.C. 1395b–3 note), as amended by section 3306 of the Patient Protection and Affordable Care Act Public Law 111–148), section 610 of the American Taxpayer Relief Act of 2012 (Public Law 112–240), and section 1110 of the Pathway for SGR Reform Act of 2013 (Public Law 113–67), is amended—
(1) in clause (iii), by striking and at the end;
(2) by striking clause (iv); and
(3) by adding at the end the following new clauses:
(iv) for fiscal year 2014, of $7,500,000; and
(v) for the portion of fiscal year 2015 before April 1, 2015, of $3,750,000.
.
(b)
Additional funding for area agencies on aging
Subsection (b)(1)(B) of such section 119, as so amended, is amended—
(1) in clause (iii), by striking and at the end;
(2) by striking clause (iv); and
(3) by inserting after clause (iii) the following new clauses:
(iv) for fiscal year 2014, of $7,500,000; and
(v) for the portion of fiscal year 2015 before April 1, 2015, of $3,750,000.
.
(c)
Additional funding for aging and disability resource centers
Subsection (c)(1)(B) of such section 119, as so amended, is amended—
(1) in clause (iii), by striking and at the end;
(2) by striking clause (iv); and
(3) by inserting after clause (iii) the following new clauses:
(iv) for fiscal year 2014, of $5,000,000; and
(v) for the portion of fiscal year 2015 before April 1, 2015, of $2,500,000.
.
(d)
Additional funding for contract with the national center for benefits and outreach enrollment
Subsection (d)(2) of such section 119, as so amended, is amended—
(1) in clause (iii), by striking and at the end;
(2) by striking clause (iv); and
(3) by inserting after clause (iii) the following new clauses:
(iv) for fiscal year 2014, of $5,000,000; and
(v) for the portion of fiscal year 2015 before April 1, 2015, of $2,500,000.
.
111.
Extension of two-midnight rule
(a)
Continuation of certain medical review activities
The Secretary of Health and Human Services may continue medical review activities described in the
notice entitled Selecting Hospital Claims for Patient Status Reviews: Admissions On or After October 1, 2013, posted on the Internet website of the Centers for Medicare & Medicaid Services, through the first 6 months of fiscal year 2015 for such additional hospital
claims as the Secretary determines appropriate.
(b)
Limitation
The Secretary of Health and Human Services shall not conduct patient status reviews (as described
in such notice) on a post-payment review basis through recovery audit
contractors under section 1893(h) of the Social Security Act (42 U.S.C. 1395ddd(h)) for inpatient claims with dates of admission October 1, 2013, through March 31, 2015, unless
there is evidence of systematic gaming, fraud, abuse, or delays in the
provision of care by a provider of services (as defined in section 1861(u)
of such Act (42 U.S.C. 1395x(u))).
112.
Technical changes to Medicare LTCH amendments
(a)
In general
Subclauses (I) and (II) of section 1886(m)(6)(C)(iv) of the Social Security Act (42 U.S.C. 1395ww(m)(6)(C)(iv)) are each amended by striking discharges and inserting Medicare fee-for-service discharges.
(b)
MMSEA correction
Section 114(d) of the Medicare, Medicaid, and SCHIP Extension Act of 2007 (42 U.S.C. 1395ww note), as amended by sections 3106(b) and 10312(b) of Public Law 111–148 and by section 1206(b)(2) of the Pathway for SGR Reform Act of 2013 (division B of Public Law 113–67), is amended—
(1) in paragraph (1), in the matter preceding subparagraph (A), by striking January 1, 2015, and inserting on the date of the enactment of paragraph (7) of this subsection;
(2) in paragraph (6), by striking January 1, 2015, and inserting on the date of the enactment of paragraph (7) of this subsection; and
(3) by adding at the end the following new paragraph:
(7)
Additional exception for certain long-term care hospitals
The moratorium under paragraph (1)(A) shall not apply to a long-term care hospital that—
(A) began its qualifying period for payment as a long-term care hospital under section 412.23(e) of title 42, Code of Federal Regulations, on or before the date of enactment of this paragraph;
(B) has a binding written agreement as of the date of the enactment of this paragraph with an outside,
unrelated party for the actual construction, renovation, lease, or
demolition for a long-term care hospital, and has expended, before such
date of enactment, at least 10 percent of the estimated cost of the
project (or, if less, $2,500,000); or
(C) has obtained an approved certificate of need in a State where one is required on or before such
date of enactment.
.
(c)
Additional amendments
Section 1206(a) of the Pathway for SGR Reform Act of 2013 (division B of Public Law 113–67) is amended—
(1) in paragraph (2)(A), by striking Assessment and inserting Advisory; and
(2) in paragraph (3)(B), by striking shall not apply to a hospital that is classified as of December 10, 2013, as a subsection (d)
hospital (as defined in section 1886(d)(1)(B) of the Social Security Act, 42 U.S.C. 1395ww(d)(1)(B)) and inserting shall only apply to a hospital that is classified as of December 10, 2013, as a long-term care
hospital (as defined in section 1861(ccc) of the Social Security Act, 42 U.S.C. 1395x(ccc)).
(d)
Effective date
The amendments made by this section are effective as of the date of the enactment of this Act.
II
Other Health Provisions
201.
Extension of the qualifying individual (QI) program
(a)
Extension
Section 1902(a)(10)(E)(iv) of the Social Security Act (42 U.S.C. 1396a(a)(10)(E)(iv)) is amended by striking March 2014 and inserting March 2015.
(b)
Extending total amount available for allocation
Section 1933(g) of the Social Security Act (42 U.S.C. 1396u–3(g)) is amended—
(1) in paragraph (2)—
(A) in subparagraph (T), by striking and at the end;
(B) in subparagraph (U)—
(i) by striking March 31, 2014 and inserting September 30, 2014; and
(ii) by striking $200,000,000. and inserting $485,000,000;; and
(C) by adding at the end the following new subparagraphs:
(V) for the period that begins on October 1, 2014, and ends on December 31, 2014, the total allocation
amount is $300,000,000; and
(W) for the period that begins on January 1, 2015, and ends on March 31, 2015, the total allocation
amount is $250,000,000.
; and
(2) in paragraph (3), in the matter preceding subparagraph (A), by striking or (T) and inserting (T), or (V).
202.
Temporary extension of transitional medical assistance (TMA)
Sections 1902(e)(1)(B) and 1925(f) of the Social Security Act (42 U.S.C. 1396a(e)(1)(B), 1396r–6(f)) are each amended by striking March 31, 2014 and inserting March 31, 2015.
203.
Extension of Medicaid and CHIP express lane option
Section 1902(e)(13)(I) of the Social Security Act (42 U.S.C. 1396a(e)(13)(I)) is amended by striking September 30, 2014 and inserting September 30, 2015.
204.
Extension of special diabetes program for type I diabetes and for Indians
(a)
Special Diabetes Programs for Type I Diabetes
Section 330B(b)(2)(C) of the Public Health Service Act (42 U.S.C. 254c–2(b)(2)(C)) is amended by striking 2014 and inserting 2015.
(b)
Special Diabetes Programs for Indians
Section 330C(c)(2)(C) of the Public Health Service Act (42 U.S.C. 254c–3(c)(2)(C)) is amended by striking 2014 and inserting 2015.
205.
Extension of abstinence education
Subsections (a) and (d) of section 510 of the Social Security Act (42 U.S.C. 710) are each amended by striking 2014 and inserting 2015.
206.
Extension of personal responsibility education program (PREP)
Section 513 of the Social Security Act (42 U.S.C. 713) is amended—
(1) in paragraphs (1)(A) and (4)(A) of subsection (a), by striking 2014 and inserting 2015 each place it appears;
(2) in subsection (a)(4)(B)(i), by striking and 2014 and inserting 2014, and 2015; and
(3) in subsection (f), by striking 2014 and inserting 2015.
207.
Extension of funding for family-to-family health information centers
Section 501(c)(1)(A) of the Social Security Act (42 U.S.C. 701(c)(1)(A)) is amended—
(1) in clause (iii), by striking at the end and;
(2) in clause (iv), by striking the period at the end and inserting a semicolon and by moving the
margin to align with the margin for clause (iii); and
(3) by adding at the end the following new clauses:
(v) $2,500,000 for the portion of fiscal year 2014 on or after April 1, 2014; and
(vi) $2,500,000 for the portion of fiscal year 2015 before April 1, 2015.
.
208.
Extension of health workforce demonstration project for low-income individuals
Section 2008(c)(1) of the Social Security Act (42 U.S.C. 1397g(c)(1)) is amended by striking 2014 and inserting 2015.
209.
Extension of maternal, infant, and early childhood home visiting programs
Section 511(j) of the Social Security Act (42 U.S.C. 711(j)) is amended—
(1) in paragraph (1)—
(A) by striking and at the end of subparagraph (D);
(B) by striking the period at the end of subparagraph (E) and inserting ; and; and
(C) by adding at the end the following new subparagraph:
(F) for the period beginning on October 1, 2014, and ending on March 31, 2015, an amount equal to the
amount provided in subparagraph (E).
; and
(2) in paragraphs (2) and (3), by inserting (or portion of a fiscal year) after for a fiscal year each place it appears.
210.
Pediatric quality measures
(a)
Continuation of funding for pediatric quality measures for improving the quality of children’s
health care
Section 1139B(e) of the Social Security Act (42 U.S.C. 1320b–9b(e)) is amended by adding at the end
the following: Of the funds appropriated under this subsection, not less than $15,000,000 shall be used to carry
out section 1139A(b)..
(b)
Elimination of restriction on Medicaid quality measurement program
Section 1139B(b)(5)(A) of the Social Security Act (42 U.S.C. 1320b–9b(b)(5)(A)) is amended by
striking The aggregate amount awarded by the Secretary for grants and contracts for the development,
testing, and validation of emerging and innovative evidence-based measures
under such program shall equal the aggregate amount awarded by the
Secretary for grants under section 1139A(b)(4)(A).
211.
Delay of effective date for Medicaid amendments relating to beneficiary liability settlements
Effective as if included in the enactment of the Bipartisan Budget Act of 2013 (Public Law 113–67), section 202(c) of such Act is amended by striking October 1, 2014 and inserting October 1, 2016.
212.
Delay in transition from ICD–9 TO ICD–10 code sets
The Secretary of Health and Human Services may not, prior to October 1, 2015, adopt ICD–10 code
sets as the standard for code sets under section 1173(c) of the Social
Security Act (42 U.S.C. 1320d–2(c)) and section 162.1002 of title 45, Code of Federal Regulations.
213.
Elimination of limitation on deductibles for employer-sponsored health plans
(a)
In general
Section 1302(c) of the Patient Protection and Affordable Care Act (Public Law 111–148; 42 U.S.C. 18022(c)) is amended—
(1) by striking paragraph (2); and
(2) in paragraph (4)(A), by striking paragraphs (1)(B)(i) and (2)(B)(i) and inserting paragraph (1)(B)(i).
(b)
Conforming amendment
Section 2707(b) of the Public Health Service Act (42 U.S.C. 300gg–6(b)) is amended by striking paragraphs (1) and (2) and inserting paragraph (1).
(c)
Effective date
The amendments made by this Act shall be effective as if included in the enactment of the Patient
Protection and Affordable Care Act (Public Law 111–148).
214.
GAO report on the Children’s Hospital Graduate Medical Education Program
(a)
In general
In the case that the Children’s Hospital GME Support Reauthorization Act of 2013 is enacted into
law, the Comptroller General of the United States shall, not later than
November 30, 2017, conduct an independent evaluation, and submit to the
appropriate committees of Congress a report, concerning the implementation
of section 340E(h) of the Public Health Service Act, as added by section 3
of the Children’s Hospital GME Support Reauthorization Act of 2013.
(b)
Content
The report described in subsection (a) shall review and assess each of the following, with respect
to hospitals receiving payments under such section 340E(h) during the
period of fiscal years 2015 through 2017:
(1) The number and type of such hospitals that applied for such payments.
(2) The number and type of such hospitals receiving such payments.
(3) The amount of such payments awarded to such hospitals.
(4) How such hospitals used such payments.
(5) The impact of such payments on—
(A) the number of pediatric providers; and
(B) health care needs of children.
215.
Skilled nursing facility value-based purchasing
(a)
In general
Section 1888 of the Social Security Act (42 U.S.C. 1395yy) is amended by adding at the end the following new subsection:
(g)
Skilled nursing facility readmission measure
(1)
Readmission measure
Not later than October 1, 2015, the Secretary shall specify a skilled nursing facility all-cause
all-condition hospital readmission measure (or any successor to such a
measure).
(2)
Resource use measure
Not later than October 1, 2016, the Secretary shall specify a measure to reflect an all-condition
risk-adjusted potentially preventable hospital readmission rate for
skilled nursing facilities.
(3)
Measure adjustments
When specifying the measures under paragraphs (1) and (2), the Secretary shall devise a methodology
to achieve a high level of reliability and validity, especially for
skilled nursing facilities with a low volume of readmissions.
(4)
Pre-rulemaking process (measure application partnership process)
The application of the provisions of section 1890A shall be optional in the case of a measure
specified under paragraph (1) and a measure specified under paragraph (2).
(5)
Feedback reports to skilled nursing facilities
Beginning October 1, 2016, and every quarter thereafter, the Secretary shall provide confidential
feedback reports to skilled nursing facilities on the performance of such
facilities with respect to a measure specified under paragraph (1) or (2).
(6)
Public reporting of skilled nursing facilities
(A)
In general
Subject to subparagraphs (B) and (C), the Secretary shall establish procedures for making available
to the public by posting on the Nursing Home Compare Medicare website (or
a successor website) described in section 1819(i) information on the
performance of skilled nursing facilities with respect to a measure
specified under paragraph (1) and a measure specified under paragraph (2).
(B)
Opportunity to review
The procedures under subparagraph (A) shall ensure that a skilled nursing facility has the
opportunity to review and submit corrections to the information that is to
be made public with respect to the facility prior to such information
being made public.
(C)
Timing
Such procedures shall provide that the information described in subparagraph (A) is made publicly
available beginning not later than October 1, 2017.
(7)
Non-application of Paperwork Reduction Act
Chapter 35 of title 44, United States Code (commonly referred to as the ‘Paperwork Reduction Act of 1995’)
shall not apply to this subsection.
.
(b)
Value-Based purchasing program for skilled nursing facilities
Section 1888 of the Social Security Act (42 U.S.C. 1395yy), as amended by subsection (a), is further amended by adding at the end the following new
subsection:
(h)
Skilled nursing facility value-Based purchasing program
(1)
Establishment
(A)
In general
Subject to the succeeding provisions of this subsection, the Secretary shall establish a skilled
nursing facility value-based purchasing program (in this subsection
referred to as the SNF VBP Program) under which value-based incentive payments are made in a fiscal year to skilled nursing
facilities.
(B)
Program to begin in fiscal year 2019
The SNF VBP Program shall apply to payments for services furnished on or after October 1, 2018.
(2)
Application of measures
(A)
In general
The Secretary shall apply the measure specified under subsection (g)(1) for purposes of the SNF VBP
Program.
(B)
Replacement
For purposes of the SNF VBP Program, the Secretary shall apply the measure specified under (g)(2)
instead of the measure specified under (g)(1) as soon as practicable.
(3)
Performance standards
(A)
Establishment
The Secretary shall establish performance standards with respect to the measure applied under
paragraph (2) for a performance period for a fiscal year.
(B)
Higher of achievement and improvement
The performance standards established under subparagraph (A) shall include levels of achievement
and improvement. In calculating the SNF performance score under paragraph
(4), the Secretary shall use the higher of either improvement or
achievement.
(C)
Timing
The Secretary shall establish and announce the performance standards established under subparagraph
(A) not later than 60 days prior to the beginning of the performance
period for the fiscal year involved.
(4)
SNF performance score
(A)
In general
The Secretary shall develop a methodology for assessing the total performance of each skilled
nursing facility based on performance standards established under
paragraph (3) with respect to the measure applied under paragraph (2).
Using such methodology, the Secretary shall provide for an assessment (in
this subsection referred to as the SNF performance score) for each skilled nursing facility for each such performance period.
(B)
Ranking of SNF performance scores
The Secretary shall, for the performance period for each fiscal year, rank the SNF performance
scores determined under subparagraph (A) from low to high.
(5)
Calculation of value-based incentive payments
(A)
In general
With respect to a skilled nursing facility, based on the ranking under paragraph (4)(B) for a
performance period for a fiscal year, the Secretary shall increase the
adjusted Federal per diem rate determined under subsection (e)(4)(G)
otherwise applicable to such skilled nursing facility (and after
application of paragraph (6)) for services furnished by such facility
during such fiscal year by the value-based incentive payment amount under
subparagraph (B).
(B)
Value-based incentive payment amount
The value-based incentive payment amount for services furnished by a skilled nursing facility in a
fiscal year shall be equal to the product of—
(i) the adjusted Federal per diem rate determined under subsection (e)(4)(G) otherwise applicable to
such skilled nursing facility for such services furnished by the skilled
nursing facility during such fiscal year; and
(ii) the value-based incentive payment percentage specified under subparagraph (C) for the skilled
nursing facility for such fiscal year.
(C)
Value-based incentive payment percentage
(i)
In general
The Secretary shall specify a value-based incentive payment percentage for a skilled nursing
facility for a fiscal year which may include a zero percentage.
(ii)
Requirements
In specifying the value-based incentive payment percentage for each skilled nursing facility for a
fiscal year under clause (i), the Secretary shall ensure that—
(I) such percentage is based on the SNF performance score of the skilled nursing facility provided
under paragraph (4) for the performance period for such fiscal year;
(II) the application of all such percentages in such fiscal year results in an appropriate distribution
of value-based incentive payments under subparagraph (B) such that—
(aa) skilled nursing facilities with the highest rankings under paragraph (4)(B) receive the highest
value-based incentive payment amounts under subparagraph (B);
(bb) skilled nursing facilities with the lowest rankings under paragraph (4)(B) receive the lowest
value-based incentive payment amounts under subparagraph (B); and
(cc) in the case of skilled nursing facilities in the lowest 40 percent of the ranking under paragraph
(4)(B), the payment rate under subparagraph (A) for services furnished by
such facility during such fiscal year shall be less than the payment rate
for such services for such fiscal year that would otherwise apply under
subsection (e)(4)(G) without application of this subsection; and
(III) the total amount of value-based incentive payments under this paragraph for all skilled nursing
facilities in such fiscal year shall be greater than or equal to 50
percent, but not greater than 70 percent, of the total amount of the
reductions to payments for such fiscal year under paragraph (6), as
estimated by the Secretary.
(6)
Funding for value-based incentive payments
(A)
In general
The Secretary shall reduce the adjusted Federal per diem rate determined under subsection (e)(4)(G)
otherwise applicable to a skilled nursing facility for services furnished
by such facility during a fiscal year (beginning with fiscal year 2019) by
the applicable percent (as defined in subparagraph (B)). The Secretary
shall make such reductions for all skilled nursing facilities in the
fiscal year involved, regardless of whether or not the skilled nursing
facility has been determined by the Secretary to have earned a value-based
incentive payment under paragraph (5) for such fiscal year.
(B)
Applicable percent
For purposes of subparagraph (A), the term applicable percent means, with respect to fiscal year 2019 and succeeding fiscal years, 2 percent.
(7)
Announcement of net result of adjustments
Under the SNF VBP Program, the Secretary shall, not later than 60 days prior to the fiscal year
involved, inform each skilled nursing facility of the adjustments to
payments to the skilled nursing facility for services furnished by such
facility during the fiscal year under paragraphs (5) and (6).
(8)
No effect in subsequent fiscal years
The value-based incentive payment under paragraph (5) and the payment reduction under paragraph (6)
shall each apply only with respect to the fiscal year involved, and the
Secretary shall not take into account such value-based incentive payment
or payment reduction in making payments to a skilled nursing facility
under this section in a subsequent fiscal year.
(9)
Public reporting
(A)
SNF specific information
The Secretary shall make available to the public, by posting on the Nursing Home Compare Medicare
website (or a successor website) described in section 1819(i) in an easily
understandable format, information regarding the performance of individual
skilled nursing facilities under the SNF VBP Program, with respect to a
fiscal year, including—
(i) the SNF performance score of the skilled nursing facility for such fiscal year; and
(ii) the ranking of the skilled nursing facility under paragraph (4)(B) for the performance period for
such fiscal year.
(B)
Aggregate information
The Secretary shall periodically post on the Nursing Home Compare Medicare website (or a successor
website) described in section 1819(i) aggregate information on the SNF VBP
Program, including—
(i) the range of SNF performance scores provided under paragraph (4)(A); and
(ii) the number of skilled nursing facilities receiving value-based incentive payments under paragraph
(5) and the range and total amount of such value-based incentive payments.
(10)
Limitation on review
There shall be no administrative or judicial review under section 1869, section 1878, or otherwise
of the following:
(A) The methodology used to determine the value-based incentive payment percentage and the amount of
the value-based incentive payment under paragraph (5).
(B) The determination of the amount of funding available for such value-based incentive payments under
paragraph (5)(C)(ii)(III) and the payment reduction under paragraph (6).
(C) The establishment of the performance standards under paragraph (3) and the performance period.
(D) The methodology developed under paragraph (4) that is used to calculate SNF performance scores and
the calculation of such scores.
(E) The ranking determinations under paragraph (4)(B).
(11)
Funding for program management
The Secretary shall provide for the one time transfer from the Federal Hospital Insurance Trust
Fund established under section 1817 to the Centers for Medicare & Medicaid Services Program Management Account of—
(A) for purposes of subsection (g)(2), $2,000,000; and
(B) for purposes of implementing this subsection, $10,000,000.
Such funds shall remain available until expended.
.
(c)
MedPAC study
Not later than June 30, 2021, the Medicare Payment Advisory Commission shall submit to Congress a
report that reviews the progress of the skilled nursing facility
value-based purchasing program established under section 1888(h) of the
Social Security Act, as added by subsection (b), and makes
recommendations, as appropriate, on any improvements that should be made
to such program. For purposes of the previous sentence, the Medicare
Payment Advisory Commission shall consider any unintended consequences
with respect to such skilled nursing facility value-based purchasing
program and any potential adjustments to the readmission measure specified
under section 1888(g)(1) of such Act, as added by subsection (a), for
purposes of determining the effect of the socio-economic status of a
beneficiary under the Medicare program under title XVIII of the Social
Security Act for the SNF performance score of a skilled nursing facility
provided under section 1888(h)(4) of such Act, as added by subsection (b).
216.
Improving Medicare policies for clinical diagnostic laboratory tests
(a)
In general
Title XVIII of the Social Security Act is amended by inserting after section 1834 (42 U.S.C. 1395m) the following new section:
1834A.
Improving policies for clinical diagnostic laboratory tests
(a)
Reporting of private sector payment rates for establishment of Medicare payment rates
(1)
In general
Beginning January 1, 2016, and every 3 years thereafter (or, annually, in the case of reporting
with respect to an advanced diagnostic laboratory test, as defined in
subsection (d)(5)), an applicable laboratory (as defined in paragraph (2))
shall report to the Secretary, at a time specified by the Secretary,
applicable information (as defined in paragraph (3)) for a data collection
period (as defined in paragraph (4)) for each clinical diagnostic
laboratory test that the laboratory furnishes during such period for which
payment is made under this part.
(2)
Definition of applicable laboratory
In this section, the term applicable laboratory means a laboratory that, with respect to its revenues under this title, a majority of such
revenues are from this section, section 1833(h), or section 1848. The
Secretary may establish a low volume or low expenditure threshold for
excluding a laboratory from the definition of applicable laboratory under
this paragraph, as the Secretary determines appropriate.
(3)
Applicable information defined
(A)
In general
In this section, subject to subparagraph (B), the term applicable information means, with respect to a laboratory test for a data collection period, the following:
(i) The payment rate (as determined in accordance with paragraph (5)) that was paid by each private
payor for the test during the period.
(ii) The volume of such tests for each such payor for the period.
(B)
Exception for certain contractual arrangements
Such term shall not include information with respect to a laboratory test for which payment is made
on a capitated basis or other similar payment basis during the data
collection period.
(4)
Data collection period defined
In this section, the term data collection period means a period of time, such as a previous 12 month period, specified by the Secretary.
(5)
Treatment of discounts
The payment rate reported by a laboratory under this subsection shall reflect all discounts,
rebates, coupons, and other price concessions, including those described
in section 1847A(c)(3).
(6)
Ensuring complete reporting
In the case where an applicable laboratory has more than one payment rate for the same payor for
the same test or more than one payment rate for different payors for the
same test, the applicable laboratory shall report each such payment rate
and the volume for the test at each such rate under this subsection.
Beginning with January 1, 2019, the Secretary may establish rules to
aggregate reporting with respect to the situations described in the
preceding sentence.
(7)
Certification
An officer of the laboratory shall certify the accuracy and completeness of the information
reported under this subsection.
(8)
Private payor defined
In this section, the term private payor means the following:
(A) A health insurance issuer and a group health plan (as such terms are defined in section 2791 of the
Public Health Service Act).
(B) A Medicare Advantage plan under part C.
(C) A medicaid managed care organization (as defined in section 1903(m)).
(9)
Civil money penalty
(A)
In general
If the Secretary determines that an applicable laboratory has failed to report or made a
misrepresentation or omission in reporting information under this
subsection with respect to a clinical diagnostic laboratory test, the
Secretary may apply a civil money penalty in an amount of up to $10,000
per day for each failure to report or each such misrepresentation or
omission.
(B)
Application
The provisions of section 1128A (other than subsections (a) and (b)) shall apply to a civil money
penalty under this paragraph in the same manner as they apply to a civil
money penalty or proceeding under section 1128A(a).
(10)
Confidentiality of information
Notwithstanding any other provision of law, information disclosed by a laboratory under this
subsection is confidential and shall not be disclosed by the Secretary or
a Medicare contractor in a form that discloses the identity of a specific
payor or laboratory, or prices charged or payments made to any such
laboratory, except—
(A) as the Secretary determines to be necessary to carry out this section;
(B) to permit the Comptroller General to review the information provided;
(C) to permit the Director of the Congressional Budget Office to review the information provided; and
(D) to permit the Medicare Payment Advisory Commission to review the information provided.
(11)
Protection from public disclosure
A payor shall not be identified on information reported under this subsection. The name of an
applicable laboratory under this subsection shall be exempt from
disclosure under section 552(b)(3) of title 5, United States Code.
(12)
Regulations
Not later than June 30, 2015, the Secretary shall establish through notice and comment rulemaking
parameters for data collection under this subsection.
(b)
Payment for clinical diagnostic laboratory tests
(1)
Use of private payor rate information to determine Medicare payment rates
(A)
In general
Subject to paragraph (3) and subsections (c) and (d), in the case of a clinical diagnostic
laboratory test furnished on or after January 1, 2017, the payment amount
under this section shall be equal to the weighted median determined for
the test under paragraph (2) for the most recent data collection period.
(B)
Application of payment amounts to hospital laboratories
The payment amounts established under this section shall apply to a clinical diagnostic laboratory
test furnished by a hospital laboratory if such test is paid for
separately, and not as part of a bundled payment under section 1833(t).
(2)
Calculation of weighted median
For each laboratory test with respect to which information is reported under subsection (a) for a
data collection period, the Secretary shall calculate a weighted median
for the test for the period, by arraying the distribution of all payment
rates reported for the period for each test weighted by volume for each
payor and each laboratory.
(3)
Phase-in of reductions from private payor rate implementation
(A)
In general
Payment amounts determined under this subsection for a clinical diagnostic laboratory test for each
of 2017 through 2022 shall not result in a reduction in payments for a
clinical diagnostic laboratory test for the year of greater than the
applicable percent (as defined in subparagraph (B)) of the amount of
payment for the test for the preceding year.
(B)
Applicable percent defined
In this paragraph, the term applicable percent means—
(i) for each of 2017 through 2019, 10 percent; and
(ii) for each of 2020 through 2022, 15 percent.
(C)
No application to new tests
This paragraph shall not apply to payment amounts determined under this section for either of the
following.
(i) A new test under subsection (c).
(ii) A new advanced diagnostic test (as defined in subsection (d)(5)) under subsection (d).
(4)
Application of market rates
(A)
In general
Subject to paragraph (3), once established for a year following a data collection period, the
payment amounts under this subsection shall continue to apply until the
year following the next data collection period.
(B)
Other adjustments not applicable
The payment amounts under this section shall not be subject to any adjustment (including any
geographic adjustment, budget neutrality adjustment, annual update, or
other adjustment).
(5)
Sample collection fee
In the case of a sample collected from an individual in a skilled nursing facility or by a
laboratory on behalf of a home health agency, the nominal fee that would
otherwise apply under section 1833(h)(3)(A) shall be increased by $2.
(c)
Payment for new tests that are not advanced diagnostic laboratory tests
(1)
Payment during initial period
In the case of a clinical diagnostic laboratory test that is assigned a new or substantially
revised HCPCS code on or after the date of enactment of this section, and
which is not an advanced diagnostic laboratory test (as defined in
subsection (d)(5)), during an initial period until payment rates under
subsection (b) are established for the test, payment for the test shall be
determined—
(A) using cross-walking (as described in section 414.508(a) of title 42, Code of Federal Regulations, or any successor regulation) to the most appropriate
existing test under the fee schedule under this section during that
period; or
(B) if no existing test is comparable to the new test, according to the gapfilling process described in
paragraph (2).
(2)
Gapfilling process described
The gapfilling process described in this paragraph shall take into account the following sources of
information to determine gapfill amounts, if available:
(A) Charges for the test and routine discounts to charges.
(B) Resources required to perform the test.
(C) Payment amounts determined by other payors.
(D) Charges, payment amounts, and resources required for other tests that may be comparable or
otherwise relevant.
(E) Other criteria the Secretary determines appropriate.
(3)
Additional consideration
In determining the payment amount under crosswalking or gapfilling processes under this subsection,
the Secretary shall consider recommendations from the panel established
under subsection (f)(1).
(4)
Explanation of payment rates
In the case of a clinical diagnostic laboratory test for which payment is made under this
subsection, the Secretary shall make available to the public an
explanation of the payment rate for the test, including an explanation of
how the criteria described in paragraph (2) and paragraph (3) are applied.
(d)
Payment for new advanced diagnostic laboratory tests
(1)
Payment during initial period
(A)
In general
In the case of an advanced diagnostic laboratory test for which payment has not been made under the
fee schedule under section 1833(h) prior to the date of enactment of this
section, during an initial period of three quarters, the payment amount
for the test for such period shall be based on the actual list charge for
the laboratory test.
(B)
Actual list charge
For purposes of subparagraph (A), the term actual list charge, with respect to a laboratory test furnished during such period, means the publicly available rate
on the first day at which the test is available for purchase by a private
payor.
(2)
Special rule for timing of initial reporting
With respect to an advanced diagnostic laboratory test described in paragraph (1)(A), an applicable
laboratory shall initially be required to report under subsection (a) not
later than the last day of the second quarter of the initial period under
such paragraph.
(3)
Application of market rates after initial period
Subject to paragraph (4), data reported under paragraph (2) shall be used to establish the payment
amount for an advanced diagnostic laboratory test after the initial period
under paragraph (1)(A) using the methodology described in subsection (b).
Such payment amount shall continue to apply until the year following the
next data collection period.
(4)
Recoupment if actual list charge exceeds market rate
With respect to the initial period described in paragraph (1)(A), if, after such period, the
Secretary determines that the payment amount for an advanced diagnostic
laboratory test under paragraph (1)(A) that was applicable during the
period was greater than 130 percent of the payment amount for the test
established using the methodology described in subsection (b) that is
applicable after such period, the Secretary shall recoup the difference
between such payment amounts for tests furnished during such period.
(5)
Advanced diagnostic laboratory test defined
In this subsection, the term advanced diagnostic laboratory test means a clinical diagnostic laboratory test covered under this part that is offered and furnished
only by a single laboratory and not sold for use by a laboratory other
than the original developing laboratory (or a successor owner) and meets
one of the following criteria:
(A) The test is an analysis of multiple biomarkers of DNA, RNA, or proteins combined with a unique
algorithm to yield a single patient-specific result.
(B) The test is cleared or approved by the Food and Drug Administration.
(C) The test meets other similar criteria established by the Secretary.
(e)
Coding
(1)
Temporary codes for certain new tests
(A)
In general
The Secretary shall adopt temporary HCPCS codes to identify new advanced diagnostic laboratory
tests (as defined in subsection (d)(5)) and new laboratory tests that are
cleared or approved by the Food and Drug Administration.
(B)
Duration
(i)
In general
Subject to clause (ii), the temporary code shall be effective until a permanent HCPCS code is
established (but not to exceed 2 years).
(ii)
Exception
The Secretary may extend the temporary code or establish a permanent HCPCS code, as the Secretary
determines appropriate.
(2)
Existing tests
Not later than January 1, 2016, for each existing advanced diagnostic laboratory test (as so
defined) and each existing clinical diagnostic laboratory test that is
cleared or approved by the Food and Drug Administration for which payment
is made under this part as of the date of enactment of this section, if
such test has not already been assigned a unique HCPCS code, the Secretary
shall—
(A) assign a unique HCPCS code for the test; and
(B) publicly report the payment rate for the test.
(3)
Establishment of unique identifier for certain tests
For purposes of tracking and monitoring, if a laboratory or a manufacturer requests a unique
identifier for an advanced diagnostic laboratory test (as so defined) or a
laboratory test that is cleared or approved by the Food and Drug
Administration, the Secretary shall utilize a means to uniquely track such
test through a mechanism such as a HCPCS code or modifier.
(f)
Input from clinicians and technical experts
(1)
In general
The Secretary shall consult with an expert outside advisory panel, established by the Secretary not
later than July 1, 2015, composed of an appropriate selection of
individuals with expertise, which may include molecular pathologists,
researchers, and individuals with expertise in laboratory science or
health economics, in issues related to clinical diagnostic laboratory
tests, which may include the development, validation, performance, and
application of such tests, to provide—
(A) input on—
(i) the establishment of payment rates under this section for new clinical diagnostic laboratory tests,
including whether to use crosswalking or gapfilling processes to determine
payment for a specific new test; and
(ii) the factors used in determining coverage and payment processes for new clinical diagnostic
laboratory tests; and
(B) recommendations to the Secretary under this section.
(2)
Compliance with FACA
The panel shall be subject to the Federal Advisory Committee Act (5 U.S.C. App.).
(3)
Continuation of annual meeting
The Secretary shall continue to convene the annual meeting described in section 1833(h)(8)(B)(iii)
after the implementation of this section for purposes of receiving
comments and recommendations (and data on which the recommendations are
based) as described in such section on the establishment of payment
amounts under this section.
(g)
Coverage
(1)
Issuance of coverage policies
(A)
In general
A medicare administrative contractor shall only issue a coverage policy with respect to a clinical
diagnostic laboratory test in accordance with the process for making a
local coverage determination (as defined in section 1869(f)(2)(B)),
including the appeals and review process for local coverage determinations
under part 426 of title 42, Code of Federal Regulations (or successor
regulations).
(B)
No effect on national coverage determination process
This paragraph shall not apply to the national coverage determination process (as defined in
section 1869(f)(1)(B)).
(C)
Effective date
This paragraph shall apply to coverage policies issued on or after January 1, 2015.
(2)
Designation of one or more medicare administrative contractors for clinical diagnostic laboratory
tests
The Secretary may designate one or more (not to exceed 4) medicare administrative contractors to
either establish coverage policies or establish coverage policies and
process claims for payment for clinical diagnostic laboratory tests, as
determined appropriate by the Secretary.
(h)
Implementation
(1)
Implementation
There shall be no administrative or judicial review under section 1869, section 1878, or otherwise,
of the establishment of payment amounts under this section.
(2)
Administration
Chapter 35 of title 44, United States Code, shall not apply to information collected under this section.
(3)
Funding
For purposes of implementing this section, the Secretary shall provide for the transfer, from the
Federal Supplementary Medical Insurance Trust Fund under section 1841, to
the Centers for Medicare & Medicaid Services Program Management Account, for each of fiscal years 2014 through 2018,
$4,000,000, and for each of fiscal years 2019 through 2023, $3,000,000.
Amounts transferred under the preceding sentence shall remain available
until expended.
(i)
Transitional rule
During the period beginning on the date of enactment of this section and ending on December 31,
2016, with respect to advanced diagnostic laboratory tests under this
part, the Secretary shall use the methodologies for pricing, coding, and
coverage in effect on the day before such date of enactment, which may
include cross-walking or gapfilling methods.
.
(b)
Conforming amendments
(1) Section 1833(a) of the Social Security Act (42 U.S.C. 1395l(a)) is amended—
(A) in paragraph (1)(D)—
(i) by striking (i) on the basis and inserting (i)(I) on the basis;
(ii) in subclause (I), as added by clause (i), by striking subsection (h)(1) and inserting subsection (h)(1) (for tests furnished before January 1, 2017);
(iii) by striking or (ii) and inserting or (II) under section 1834A (for tests furnished on or after January 1, 2017), the amount paid
shall be equal to 80 percent (or 100 percent, in the case of such tests
for which payment is made on an assignment-related basis) of the lesser of
the amount determined under such section or the amount of the charges
billed for the tests, or (ii); and
(iv) in clause (ii), by striking on the basis and inserting for tests furnished before January 1, 2017, on the basis;
(B) in paragraph (2)(D)—
(i) by striking (i) on the basis and inserting (i)(I) on the basis;
(ii) in subclause (I), as added by clause (i), by striking subsection (h)(1) and inserting subsection (h)(1) (for tests furnished before January 1, 2017);
(iii) by striking or (ii) and inserting or (II) under section 1834A (for tests furnished on or after January 1, 2017), the amount paid
shall be equal to 80 percent (or 100 percent, in the case of such tests
for which payment is made on an assignment-related basis or to a provider
having an agreement under section 1866) of the lesser of the amount
determined under such section or the amount of the charges billed for the
tests, or (ii); and
(iv) in clause (ii), by striking on the basis and inserting for tests furnished before January 1, 2017, on the basis;
(C) in subsection (b)(3)(B), by striking on the basis and inserting for tests furnished before January 1, 2017, on the basis;
(D) in subsection (h)(2)(A)(i), by striking and subject to and inserting and, for tests furnished before the date of enactment of section 1834A, subject to;
(E) in subsection (h)(3), in the matter preceding subparagraph (A), by striking fee schedules and inserting fee schedules (for tests furnished before January 1, 2017) or under section 1834A (for tests
furnished on or after January 1, 2017), subject to subsection (b)(5) of
such section;
(F) in subsection (h)(6), by striking In the case and inserting For tests furnished before January 1, 2017, in the case; and
(G) in subsection (h)(7), in the first sentence—
(i) by striking and (4) and inserting and (4) and section 1834A; and
(ii) by striking under this subsection and inserting under this part.
(2) Section 1869(f)(2) of the Social Security Act (42 U.S.C. 1395ff(f)(2)) is amended by adding at the end the following new subparagraph:
(C)
Local coverage determinations for clinical diagnostic laboratory tests
For provisions relating to local coverage determinations for clinical diagnostic laboratory tests,
see section 1834A(g).
.
(c)
GAO study and report; Monitoring of Medicare expenditures and implementation of new payment system
for laboratory tests
(1)
GAO study and report on implementation of new payment rates for clinical diagnostic laboratory
tests
(A)
Study
The Comptroller General of the United States (in this subsection referred to as the Comptroller General) shall conduct a study on the implementation of section 1834A of the Social Security Act, as added
by subsection (a). The study shall include an analysis of—
(i) payment rates paid by private payors for laboratory tests furnished in various settings, including—
(I) how such payment rates compare across settings;
(II) the trend in payment rates over time; and
(III) trends by private payors to move to alternative payment methodologies for laboratory tests;
(ii) the conversion to the new payment rate for laboratory tests under such section;
(iii) the impact of such implementation on beneficiary access under title XVIII of the Social Security
Act;
(iv) the impact of the new payment system on laboratories that furnish a low volume of services and
laboratories that specialize in a small number of tests;
(v) the number of new Healthcare Common Procedure Coding System (HCPCS) codes issued for laboratory
tests;
(vi) the spending trend for laboratory tests under such title;
(vii) whether the information reported by laboratories and the new payment rates for laboratory tests
under such section accurately reflect market prices;
(viii) the initial list price for new laboratory tests and the subsequent reported rates for such tests
under such section;
(ix) changes in the number of advanced diagnostic laboratory tests and laboratory tests cleared or
approved by the Food and Drug Administration for which payment is made
under such section; and
(x) healthcare economic information on downstream cost impacts for such tests and decision making based
on accepted methodologies.
(B)
Report
Not later than October 1, 2018, the Comptroller General shall submit to the Committee on Ways and
Means and the Committee on Energy and Commerce of the House of
Representatives and the Committee on Finance of the Senate a report on the
study under subparagraph (A), including recommendations for such
legislation and administrative action as the Comptroller General
determines appropriate.
(2)
Monitoring of Medicare expenditures and implementation of new payment system for laboratory tests
The Inspector General of the Department of Health and Human Services shall—
(A) publicly release an annual analysis of the top 25 laboratory tests by expenditures under title
XVIII of the Social Security Act; and
(B) conduct analyses the Inspector General determines appropriate with respect to the implementation
and effect of the new payment system for laboratory tests under section
1834A of the Social Security Act, as added by subsection (a).
217.
Revisions under the Medicare ESRD prospective payment system
(a)
Delay of implementation of oral-Only policy
Section 632(b)(1) of the American Taxpayer Relief Act of 2012 (42 U.S.C. 1395rr note) is amended—
(1) by striking 2016 and inserting 2024; and
(2) by adding at the end the following new sentence: Notwithstanding section 1881(b)(14)(A)(ii) of the Social Security Act (42 U.S.C. 1395rr(b)(14)(A)(ii)), implementation of the policy described in the previous sentence shall be based on data from the
most recent year available..
(b)
Mitigation of the application of adjustment to ESRD bundled payment rate To account for changes in
the utilization of certain drugs and biologicals
(1)
In general
Section 1881(b)(14)(I) of the Social Security Act (42 U.S.C. 1395rr(b)(14)(I)) is amended by inserting and before January 1, 2015, after January 1, 2014,.
(2)
Market basket
Section 1881(b)(14)(F)(i) of the Social Security Act (42 U.S.C. 1395rr(b)(14)(F)(i)) is amended—
(A) in subclause (I)—
(i) by striking subclause (II) and inserting subclauses (II) and (III); and
(ii) by adding at the end the following new sentence: In order to accomplish the purposes of subparagraph (I) with respect to 2016, 2017, and 2018, after
determining the increase factor described in the preceding sentence for
each of 2016, 2017, and 2018, the Secretary shall reduce such increase
factor by 1.25 percentage points for each of 2016 and 2017 and by 1
percentage point for 2018.;
(B) in subclause (II), by striking For 2012 and inserting Subject to subclause (III), for 2012; and
(C) by adding at the end the following new subclause:
(III) Notwithstanding subclauses (I) and (II), in order to accomplish the purposes of subparagraph (I)
with respect to 2015, the increase factor described in subclause (I) for
2015 shall be 0.0 percent pursuant to the regulation issued by the
Secretary on December 2, 2013, entitled Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program,
and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final
Rule (78 Fed. Reg. 72156).
.
(c)
Drug designations
As part of the promulgation of annual rule for the Medicare end stage renal disease prospective
payment system under section 1881(b)(14) of the Social Security Act (42 U.S.C. 1395rr(b)(14)) for calendar year 2016, the Secretary of Health and Human Services (in this subsection referred
to as the Secretary) shall establish a process for—
(1) determining when a product is no longer an oral-only drug; and
(2) including new injectable and intravenous products into the bundled payment under such system.
(d)
Quality measures related to conditions treated by oral-Only drugs under the ESRD quality incentive
program
Section 1881(h)(2) of the Social Security Act (42 U.S.C. 1395rr(h)(2)) is amended—
(1) in subparagraph (A)—
(A) in clause (ii), by striking and at the end;
(B) by redesignating clause (iii) as clause (iv); and
(C) by inserting after clause (ii) the following new clause:
(iii) for 2016 and subsequent years, measures described in subparagraph (E)(i); and
;
(2) in subparagraph (B)(i), by striking (A)(iii) and inserting (A)(iv); and
(3) by adding at the end the following new subparagraph:
(E)
Measures specific to the conditions treated with oral-only drugs
(i)
In general
The measures described in this subparagraph are measures specified by the Secretary that are
specific to the conditions treated with oral-only drugs. To the extent
feasible, such measures shall be outcomes-based measures.
(ii)
Consultation
In specifying the measures under clause (i), the Secretary shall consult with interested
stakeholders.
(iii)
Use of endorsed measures
(I)
In general
Subject to subclause (I), any measures specified under clause (i) must have been endorsed by the
entity with a contract under section 1890(a).
(II)
Exception
If the entity with a contract under section 1890(a) has not endorsed a measure for a specified area
or topic related to measures described in clause (i) that the Secretary
determines appropriate, the Secretary may specify a measure that is
endorsed or adopted by a consensus organization recognized by the
Secretary that has expertise in clinical guidelines for kidney disease.
.
(e)
Audits of cost reports of ESRD providers as recommended by MedPAC
(1)
In general
The Secretary of Health and Human Services shall conduct audits of Medicare cost reports beginning
during 2012 for a representative sample of providers of services and renal
dialysis facilities furnishing renal dialysis services.
(2)
Funding
For purposes of carrying out paragraph (1), the Secretary of Health and Human Services shall
provide for the transfer from the Federal Supplementary Medical Insurance
Trust Fund established under section 1841 of the Social Security Act (42 U.S.C. 1395t) to the Centers for Medicare & Medicaid Services Program Management Account of $18,000,000 for fiscal year 2014. Amounts
transferred under this paragraph for a fiscal year shall be available
until expended.
218.
Quality incentives for computed tomography diagnostic imaging and promoting evidence-based care
(a)
Quality incentives To promote patient safety and public health in computed tomography diagnostic
imaging
(1)
In general
Section 1834 of the Social Security Act (42 U.S.C. 1395m) is amended by adding at the end the following new subsection:
(p)
Quality incentives To promote patient safety and public health in computed tomography
(1)
Quality incentives
In the case of an applicable computed tomography service (as defined in paragraph (2)) for which
payment is made under an applicable payment system (as defined in
paragraph (3)) and that is furnished on or after January 1, 2016, using
equipment that is not consistent with the CT equipment standard (described
in paragraph (4)), the payment amount for such service shall be reduced by
the applicable percentage (as defined in paragraph (5)).
(2)
Applicable computed tomography services defined
In this subsection, the term applicable computed tomography service means a service billed using diagnostic radiological imaging codes for computed tomography
(identified as of January 1, 2014, by HCPCS codes 70450–70498,
71250–71275, 72125–72133, 72191–72194, 73200–73206, 73700–73706,
74150–74178, 74261–74263, and 75571–75574 (and any succeeding codes).
(3)
Applicable payment system defined
In this subsection, the term applicable payment system means the following:
(A) The technical component and the technical component of the global fee under the fee schedule
established under section 1848(b).
(B) The prospective payment system for hospital outpatient department services under section 1833(t).
(4)
Consistency with CT equipment standard
In this subsection, the term not consistent with the CT equipment standard means, with respect to an applicable computed tomography service, that the service was furnished
using equipment that does not meet each of the attributes of the National
Electrical Manufacturers Association (NEMA) Standard XR–29–2013, entitled Standard Attributes on CT Equipment Related to Dose Optimization and Management. Through rulemaking, the Secretary may apply successor standards.
(5)
Applicable percentage defined
In this subsection, the term applicable percentage means—
(A) for 2016, 5 percent; and
(B) for 2017 and subsequent years, 15 percent.
(6)
Implementation
(A)
Information
The Secretary shall require that information be provided and attested to by a supplier and a
hospital outpatient department that indicates whether an applicable
computed tomography service was furnished that was not consistent with the
CT equipment standard (described in paragraph (4)). Such information may
be included on a claim and may be a modifier. Such information shall be
verified, as appropriate, as part of the periodic accreditation of
suppliers under section 1834(e) and hospitals under section 1865(a).
(B)
Administration
Chapter 35 of title 44, United States Code, shall not apply to information described in subparagraph (A).
.
(2)
Conforming amendments
(A)
Prospective payment system for hospital outpatient department services
Section 1833(t) of the Social Security Act (42 1395l(t)) is amended by adding at the end the
following new paragraph:
(20)
Not budget neutral application of reduced expenditures resulting from quality incentives for
computed tomography
The Secretary shall not take into account the reduced expenditures that result from the application
of section 1834(p) in making any budget neutrality adjustments this
subsection.
.
(B)
Physician fee schedule
Section 1848(c)(2)(B)(v) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)(B)(v)) is amended by adding at the end the following new subclause:
(VIII)
Reduced expenditures attributable to application of quality incentives for computed tomography
Effective for fee schedules established beginning with 2016, reduced expenditures attributable to
the application of the quality incentives for computed tomography under
section 1834(p)
.
(b)
Promoting evidence-Based care
(1)
In general
Section 1834 of the Social Security Act (42 U.S.C. 1395m), as amended by subsection (a), is amended by adding at the end the following new subsection:
(q)
Recognizing appropriate use criteria for certain imaging services
(1)
Program established
(A)
In general
The Secretary shall establish a program to promote the use of appropriate use criteria (as defined
in subparagraph (B)) for applicable imaging services (as defined in
subparagraph (C)) furnished in an applicable setting (as defined in
subparagraph (D)) by ordering professionals and furnishing professionals
(as defined in subparagraphs (E) and (F), respectively).
(B)
Appropriate use criteria defined
In this subsection, the term appropriate use criteria means criteria, only developed or endorsed by national professional medical specialty societies or
other provider-led entities, to assist ordering professionals and
furnishing professionals in making the most appropriate treatment decision
for a specific clinical condition for an individual. To the extent
feasible, such criteria shall be evidence-based.
(C)
Applicable imaging service defined
In this subsection, the term applicable imaging service means an advanced diagnostic imaging service (as defined in subsection (e)(1)(B)) for which the
Secretary determines—
(i)
one or more applicable appropriate use criteria specified under paragraph (2) apply;
(ii)
there are one or more qualified clinical decision support mechanisms listed under paragraph (3)(C);
and
(iii)
one or more of such mechanisms is available free of charge.
(D)
Applicable setting defined
In this subsection, the term applicable setting means a physician’s office, a hospital outpatient department (including an emergency department),
an ambulatory surgical center, and any other provider-led outpatient
setting determined appropriate by the Secretary.
(E)
Ordering professional defined
In this subsection, the term ordering professional means a physician (as defined in section 1861(r)) or a practitioner described in section
1842(b)(18)(C) who orders an applicable imaging service.
(F)
Furnishing professional defined
In this subsection, the term furnishing professional means a physician (as defined in section 1861(r)) or a practitioner described in section
1842(b)(18)(C) who furnishes an applicable imaging service.
(2)
Establishment of applicable appropriate use criteria
(A)
In general
Not later than November 15, 2015, the Secretary shall through rulemaking, and in consultation with
physicians, practitioners, and other stakeholders, specify applicable
appropriate use criteria for applicable imaging services only from among
appropriate use criteria developed or endorsed by national professional
medical specialty societies or other provider-led entities.
(B)
Considerations
In specifying applicable appropriate use criteria under subparagraph (A), the Secretary shall take
into account whether the criteria—
(i)
have stakeholder consensus;
(ii)
are scientifically valid and evidence based; and
(iii)
are based on studies that are published and reviewable by stakeholders.
(C)
Revisions
The Secretary shall review, on an annual basis, the specified applicable appropriate use criteria
to determine if there is a need to update or revise (as appropriate) such
specification of applicable appropriate use criteria and make such updates
or revisions through rulemaking.
(D)
Treatment of multiple applicable appropriate use criteria
In the case where the Secretary determines that more than one appropriate use criterion applies
with respect to an applicable imaging service, the Secretary shall apply
one or more applicable appropriate use criteria under this paragraph for
the service.
(3)
Mechanisms for consultation with applicable appropriate use criteria
(A)
Identification of mechanisms to consult with applicable appropriate use criteria
(i)
In general
The Secretary shall specify qualified clinical decision support mechanisms that could be used by
ordering professionals to consult with applicable appropriate use criteria
for applicable imaging services.
(ii)
Consultation
The Secretary shall consult with physicians, practitioners, health care technology experts, and
other stakeholders in specifying mechanisms under this paragraph.
(iii)
Inclusion of certain mechanisms
Mechanisms specified under this paragraph may include any or all of the following that meet the
requirements described in subparagraph (B)(ii):
(I)
Use of clinical decision support modules in certified EHR technology (as defined in section
1848(o)(4)).
(II)
Use of private sector clinical decision support mechanisms that are independent from certified EHR
technology, which may include use of clinical decision support mechanisms
available from medical specialty organizations.
(III)
Use of a clinical decision support mechanism established by the Secretary.
(B)
Qualified clinical decision support mechanisms
(i)
In general
For purposes of this subsection, a qualified clinical decision support mechanism is a mechanism
that the Secretary determines meets the requirements described in clause
(ii).
(ii)
Requirements
The requirements described in this clause are the following:
(I)
The mechanism makes available to the ordering professional applicable appropriate use criteria
specified under paragraph (2) and the supporting documentation for the
applicable imaging service ordered.
(II)
In the case where there is more than one applicable appropriate use criterion specified under such
paragraph for an applicable imaging service, the mechanism indicates the
criteria that it uses for the service.
(III)
The mechanism determines the extent to which an applicable imaging service ordered is consistent
with the applicable appropriate use criteria so specified.
(IV)
The mechanism generates and provides to the ordering professional a certification or documentation
that documents that the qualified clinical decision support mechanism was
consulted by the ordering professional.
(V)
The mechanism is updated on a timely basis to reflect revisions to the specification of applicable
appropriate use criteria under such paragraph.
(VI)
The mechanism meets privacy and security standards under applicable provisions of law.
(VII)
The mechanism performs such other functions as specified by the Secretary, which may include a
requirement to provide aggregate feedback to the ordering professional.
(C)
List of mechanisms for consultation with applicable appropriate use criteria
(i)
Initial list
Not later than April 1, 2016, the Secretary shall publish a list of mechanisms specified under this
paragraph.
(ii)
Periodic updating of list
The Secretary shall identify on an annual basis the list of qualified clinical decision support
mechanisms specified under this paragraph.
(4)
Consultation with applicable appropriate use criteria
(A)
Consultation by ordering professional
Beginning with January 1, 2017, subject to subparagraph (C), with respect to an applicable imaging
service ordered by an ordering professional that would be furnished in an
applicable setting and paid for under an applicable payment system (as
defined in subparagraph (D)), an ordering professional shall—
(i)
consult with a qualified decision support mechanism listed under paragraph (3)(C); and
(ii)
provide to the furnishing professional the information described in clauses (i) through (iii) of
subparagraph (B).
(B)
Reporting by furnishing professional
Beginning with January 1, 2017, subject to subparagraph (C), with respect to an applicable imaging
service furnished in an applicable setting and paid for under an
applicable payment system (as defined in subparagraph (D)), payment for
such service may only be made if the claim for the service includes the
following:
(i)
Information about which qualified clinical decision support mechanism was consulted by the ordering
professional for the service.
(ii)
Information regarding—
(I)
whether the service ordered would adhere to the applicable appropriate use criteria specified under
paragraph (2);
(II)
whether the service ordered would not adhere to such criteria; or
(III)
whether such criteria was not applicable to the service ordered.
(iii)
The national provider identifier of the ordering professional (if different from the furnishing
professional).
(C)
Exceptions
The provisions of subparagraphs (A) and (B) and paragraph (6)(A) shall not apply to the following:
(i)
Emergency services
An applicable imaging service ordered for an individual with an emergency medical condition (as
defined in section 1867(e)(1)).
(ii)
Inpatient services
An applicable imaging service ordered for an inpatient and for which payment is made under part A.
(iii)
Significant hardship
An applicable imaging service ordered by an ordering professional who the Secretary may, on a
case-by-case basis, exempt from the application of such provisions if the
Secretary determines, subject to annual renewal, that consultation with
applicable appropriate use criteria would result in a significant
hardship, such as in the case of a professional who practices in a rural
area without sufficient Internet access.
(D)
Applicable payment system defined
In this subsection, the term applicable payment system means the following:
(i)
The physician fee schedule established under section 1848(b).
(ii)
The prospective payment system for hospital outpatient department services under section 1833(t).
(iii)
The ambulatory surgical center payment systems under section 1833(i).
(5)
Identification of outlier ordering professionals
(A)
In general
With respect to applicable imaging services furnished beginning with 2017, the Secretary shall
determine, on an annual basis, no more than five percent of the total
number of ordering professionals who are outlier ordering professionals.
(B)
Outlier ordering professionals
The determination of an outlier ordering professional shall—
(i)
be based on low adherence to applicable appropriate use criteria specified under paragraph (2),
which may be based on comparison to other ordering professionals; and
(ii)
include data for ordering professionals for whom prior authorization under paragraph (6)(A)
applies.
(C)
Use of two years of data
The Secretary shall use two years of data to identify outlier ordering professionals under this
paragraph.
(D)
Process
The Secretary shall establish a process for determining when an outlier ordering professional is no
longer an outlier ordering professional.
(E)
Consultation with stakeholders
The Secretary shall consult with physicians, practitioners and other stakeholders in developing
methods to identify outlier ordering professionals under this paragraph.
(6)
Prior authorization for ordering professionals who are outliers
(A)
In general
Beginning January 1, 2020, subject to paragraph (4)(C), with respect to services furnished during a
year, the Secretary shall, for a period determined appropriate by the
Secretary, apply prior authorization for applicable imaging services that
are ordered by an outlier ordering professional identified under paragraph
(5).
(B)
Appropriate use criteria in prior authorization
In applying prior authorization under subparagraph (A), the Secretary shall utilize only the
applicable appropriate use criteria specified under this subsection.
(C)
Funding
For purposes of carrying out this paragraph, the Secretary shall provide for the transfer, from the
Federal Supplementary Medical Insurance Trust Fund under section 1841, of
$5,000,000 to the Centers for Medicare & Medicaid Services Program Management Account for each of fiscal years 2019 through 2021. Amounts
transferred under the preceding sentence shall remain available until
expended.
(7)
Construction
Nothing in this subsection shall be construed as granting the Secretary the authority to develop or
initiate the development of clinical practice guidelines or appropriate
use criteria.
.
(2)
Conforming amendment
Section 1833(t)(16) of the Social Security Act (42 U.S.C. 1395l(t)(16)) is amended by adding at the end the following new subparagraph:
(E)
Application of appropriate use criteria for certain imaging services
For provisions relating to the application of appropriate use criteria for certain imaging
services, see section 1834(q).
.
(3)
Report on experience of imaging appropriate use criteria program
Not later than 18 months after the date of the enactment of this Act, the Comptroller General of
the United States shall submit to Congress a report that includes a
description of the extent to which appropriate use criteria could be used
for other services under part B of title XVIII of the Social Security Act
(42 U.S.C. 1395j et seq.), such as radiation therapy and clinical diagnostic laboratory services.
219.
Using funding from Transitional Fund for Sustainable Growth Rate (SGR) Reform
Section 1898(b)(1) of the Social Security Act (42 U.S.C. 1395iii(b)(1)) is amended by striking $2,300,000,000 and inserting $0.
220.
Ensuring accurate valuation of services under the physician fee schedule
(a)
Authority To collect and use information on physicians’ services in the determination of relative
values
(1)
In general
Section 1848(c)(2) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)) is amended by adding at the end the following new subparagraph:
(M)
Authority to collect and use information on physicians’ services in the determination of relative
values
(i)
Collection of information
Notwithstanding any other provision of law, the Secretary may collect or obtain information on the
resources directly or indirectly related to furnishing services for which
payment is made under the fee schedule established under subsection (b).
Such information may be collected or obtained from any eligible
professional or any other source.
(ii)
Use of information
Notwithstanding any other provision of law, subject to clause (v), the Secretary may (as the
Secretary determines appropriate) use information collected or obtained
pursuant to clause (i) in the determination of relative values for
services under this section.
(iii)
Types of information
The types of information described in clauses (i) and (ii) may, at the Secretary’s discretion,
include any or all of the following:
(I)
Time involved in furnishing services.
(II)
Amounts and types of practice expense inputs involved with furnishing services.
(III)
Prices (net of any discounts) for practice expense inputs, which may include paid invoice prices or
other documentation or records.
(IV)
Overhead and accounting information for practices of physicians and other suppliers.
(V)
Any other element that would improve the valuation of services under this section.
(iv)
Information collection mechanisms
Information may be collected or obtained pursuant to this subparagraph from any or all of the
following:
(I)
Surveys of physicians, other suppliers, providers of services, manufacturers, and vendors.
(II)
Surgical logs, billing systems, or other practice or facility records.
(III)
Electronic health records.
(IV)
Any other mechanism determined appropriate by the Secretary.
(v)
Transparency of use of information
(I)
In general
Subject to subclauses (II) and (III), if the Secretary uses information collected or obtained under
this subparagraph in the determination of relative values under this
subsection, the Secretary shall disclose the information source and
discuss the use of such information in such determination of relative
values through notice and comment rulemaking.
(II)
Thresholds for use
The Secretary may establish thresholds in order to use such information, including the exclusion of
information collected or obtained from eligible professionals who use very
high resources (as determined by the Secretary) in furnishing a service.
(III)
Disclosure of information
The Secretary shall make aggregate information available under this subparagraph but shall not
disclose information in a form or manner that identifies an eligible
professional or a group practice, or information collected or obtained
pursuant to a nondisclosure agreement.
(vi)
Incentive to participate
The Secretary may provide for such payments under this part to an eligible professional that
submits such solicited information under this subparagraph as the
Secretary determines appropriate in order to compensate such eligible
professional for such submission. Such payments shall be provided in a
form and manner specified by the Secretary.
(vii)
Administration
Chapter 35 of title 44, United States Code, shall not apply to information collected or obtained under this
subparagraph.
(viii)
Definition of eligible professional
In this subparagraph, the term eligible professional has the meaning given such term in subsection (k)(3)(B).
(ix)
Funding
For purposes of carrying out this subparagraph, in addition to funds otherwise appropriated, the
Secretary shall provide for the transfer, from the Federal Supplementary
Medical Insurance Trust Fund under section 1841, of $2,000,000 to the
Centers for Medicare & Medicaid Services Program Management Account for each fiscal year beginning with fiscal year 2014.
Amounts transferred under the preceding sentence for a fiscal year shall
be available until expended.
.
(2)
Limitation on review
Section 1848(i)(1) of the Social Security Act (42 U.S.C. 1395w–4(i)(1)) is amended—
(A)
in subparagraph (D), by striking and at the end;
(B)
in subparagraph (E), by striking the period at the end and inserting , and; and
(C)
by adding at the end the following new subparagraph:
(F)
the collection and use of information in the determination of relative values under subsection
(c)(2)(M).
.
(b)
Authority for alternative approaches To establishing practice expense relative values
Section 1848(c)(2) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)), as amended by subsection (a), is amended by adding at the end the following new subparagraph:
(N)
Authority for alternative approaches to establishing practice expense relative values
The Secretary may establish or adjust practice expense relative values under this subsection using
cost, charge, or other data from suppliers or providers of services,
including information collected or obtained under subparagraph (M).
.
(c)
Revised and expanded identification of potentially misvalued codes
Section 1848(c)(2)(K)(ii) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)(K)(ii)) is amended to read as follows:
(ii)
Identification of potentially misvalued codes
For purposes of identifying potentially misvalued codes pursuant to clause (i)(I), the Secretary
shall examine codes (and families of codes as appropriate) based on any or
all of the following criteria:
(I)
Codes that have experienced the fastest growth.
(II)
Codes that have experienced substantial changes in practice expenses.
(III)
Codes that describe new technologies or services within an appropriate time period (such as 3
years) after the relative values are initially established for such codes.
(IV)
Codes which are multiple codes that are frequently billed in conjunction with furnishing a single
service.
(V)
Codes with low relative values, particularly those that are often billed multiple times for a
single treatment.
(VI)
Codes that have not been subject to review since implementation of the fee schedule.
(VII)
Codes that account for the majority of spending under the physician fee schedule.
(VIII)
Codes for services that have experienced a substantial change in the hospital length of stay or
procedure time.
(IX)
Codes for which there may be a change in the typical site of service since the code was last
valued.
(X)
Codes for which there is a significant difference in payment for the same service between different
sites of service.
(XI)
Codes for which there may be anomalies in relative values within a family of codes.
(XII)
Codes for services where there may be efficiencies when a service is furnished at the same time as
other services.
(XIII)
Codes with high intra-service work per unit of time.
(XIV)
Codes with high practice expense relative value units.
(XV)
Codes with high cost supplies.
(XVI)
Codes as determined appropriate by the Secretary.
.
(d)
Target for relative value adjustments for misvalued services
(1)
In general
Section 1848(c)(2) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)), as amended by subsections (a) and (b), is amended by adding at the end the following new
subparagraph:
(O)
Target for relative value adjustments for misvalued services
With respect to fee schedules established for each of 2017 through 2020, the following shall apply:
(i)
Determination of net reduction in expenditures
For each year, the Secretary shall determine the estimated net reduction in expenditures under the
fee schedule under this section with respect to the year as a result of
adjustments to the relative values established under this paragraph for
misvalued codes.
(ii)
Budget neutral redistribution of funds if target met and counting overages towards the target for
the succeeding year
If the estimated net reduction in expenditures determined under clause (i) for the year is equal to
or greater than the target for the year—
(I)
reduced expenditures attributable to such adjustments shall be redistributed for the year in a
budget neutral manner in accordance with subparagraph (B)(ii)(II); and
(II)
the amount by which such reduced expenditures exceeds the target for the year shall be treated as a
reduction in expenditures described in clause (i) for the succeeding year,
for purposes of determining whether the target has or has not been met
under this subparagraph with respect to that year.
(iii)
Exemption from budget neutrality if target not met
If the estimated net reduction in expenditures determined under clause (i) for the year is less
than the target for the year, reduced expenditures in an amount equal to
the target recapture amount shall not be taken into account in applying
subparagraph (B)(ii)(II) with respect to fee schedules beginning with
2017.
(iv)
Target recapture amount
For purposes of clause (iii), the target recapture amount is, with respect to a year, an amount
equal to the difference between—
(I)
the target for the year; and
(II)
the estimated net reduction in expenditures determined under clause (i) for the year.
(v)
Target
For purposes of this subparagraph, with respect to a year, the target is calculated as 0.5 percent
of the estimated amount of expenditures under the fee schedule under this
section for the year.
.
(2)
Conforming amendment
Section 1848(c)(2)(B)(v) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)(B)(v)) is amended by adding at the end the following new subclause:
(VIII)
Reductions for misvalued services if target not met
Effective for fee schedules beginning with 2017, reduced expenditures attributable to the
application of the target recapture amount described in subparagraph
(O)(iii).
.
(e)
Phase-In of significant relative value unit (RVU) reductions
(1)
In general
Section 1848(c) of the Social Security Act (42 U.S.C. 1395w–4(c)) is amended by adding at the end the following new paragraph:
(7)
Phase-in of significant relative value unit (RVU) reductions
Effective for fee schedules established beginning with 2017, for services that are not new or
revised codes, if the total relative value units for a service for a year
would otherwise be decreased by an estimated amount equal to or greater
than 20 percent as compared to the total relative value units for the
previous year, the applicable adjustments in work, practice expense, and
malpractice relative value units shall be phased-in over a 2-year period.
.
(2)
Conforming amendments
Section 1848(c)(2) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)) is amended—
(A)
in subparagraph (B)(ii)(I), by striking subclause (II) and inserting subclause (II) and paragraph (7); and
(B)
in subparagraph (K)(iii)(VI)—
(i)
by striking provisions of subparagraph (B)(ii)(II) and inserting provisions of subparagraph (B)(ii)(II) and paragraph (7); and
(ii)
by striking under subparagraph (B)(ii)(II) and inserting under subparagraph (B)(ii)(I).
(f)
Authority To smooth relative values within groups of services
Section 1848(c)(2)(C) of the Social Security Act (42 U.S.C. 1395w–4(c)(2)(C)) is amended—
(1)
in each of clauses (i) and (iii), by striking the service and inserting the service or group of services each place it appears; and
(2)
in the first sentence of clause (ii), by inserting or group of services before the period.
(g)
GAO study and report on Relative Value Scale Update Committee
(1)
Study
The Comptroller General of the United States (in this subsection referred to as the Comptroller General) shall conduct a study of the processes used by the Relative Value Scale Update Committee (RUC) to
provide recommendations to the Secretary of Health and Human Services
regarding relative values for specific services under the Medicare
physician fee schedule under section 1848 of the Social Security Act (42 U.S.C. 1395w–4).
(2)
Report
Not later than 1 year after the date of the enactment of this Act, the Comptroller General shall
submit to Congress a report containing the results of the study conducted
under paragraph (1).
(h)
Adjustment to Medicare payment localities
(1)
In general
Section 1848(e) of the Social Security Act (42 U.S.C. 1395w–4(e)) is amended by adding at the end the following new paragraph:
(6)
Use of MSAs as fee schedule areas in California
(A)
In general
Subject to the succeeding provisions of this paragraph and notwithstanding the previous provisions
of this subsection, for services furnished on or after January 1, 2017,
the fee schedule areas used for payment under this section applicable to
California shall be the following:
(i)
Each Metropolitan Statistical Area (each in this paragraph referred to as an MSA), as defined by the Director of the Office of Management and Budget as of December 31 of the
previous year, shall be a fee schedule area.
(ii)
All areas not included in an MSA shall be treated as a single rest-of-State fee schedule area.
(B)
Transition for MSAs previously in rest-of-State payment locality or in locality 3
(i)
In general
For services furnished in California during a year beginning with 2017 and ending with 2021 in an
MSA in a transition area (as defined in subparagraph (D)), subject to
subparagraph (C), the geographic index values to be applied under this
subsection for such year shall be equal to the sum of the following:
(I)
Current law component
The old weighting factor (described in clause (ii)) for such year multiplied by the geographic
index values under this subsection for the fee schedule area that included
such MSA that would have applied in such area (as estimated by the
Secretary) if this paragraph did not apply.
(II)
MSA-based component
The MSA-based weighting factor (described in clause (iii)) for such year multiplied by the
geographic index values computed for the fee schedule area under
subparagraph (A) for the year (determined without regard to this
subparagraph).
(ii)
Old weighting factor
The old weighting factor described in this clause—
(I)
for 2017, is 5/6; and
(II)
for each succeeding year, is the old weighting factor described in this clause for the previous
year minus 1/6.
(iii)
MSA-based weighting factor
The MSA-based weighting factor described in this clause for a year is 1 minus the old weighting
factor under clause (ii) for that year.
(C)
Hold harmless
For services furnished in a transition area in California during a year beginning with 2017, the
geographic index values to be applied under this subsection for such year
shall not be less than the corresponding geographic index values that
would have applied in such transition area (as estimated by the Secretary)
if this paragraph did not apply.
(D)
Transition area defined
In this paragraph, the term transition area means each of the following fee schedule areas for 2013:
(i)
The rest-of-State payment locality.
(ii)
Payment locality 3.
(E)
References to fee schedule areas
Effective for services furnished on or after January 1, 2017, for California, any reference in this
section to a fee schedule area shall be deemed a reference to a fee
schedule area established in accordance with this paragraph.
.
(2)
Conforming amendment to definition of fee schedule area
Section 1848(j)(2) of the Social Security Act (42 U.S.C. 1395w–4(j)(2)) is amended by striking The term and inserting Except as provided in subsection (e)(6)(D), the term.
(i)
Disclosure of data used To establish multiple procedure payment reduction policy
The Secretary of Health and Human Services shall make publicly available the information used to
establish the multiple procedure payment reduction policy to the
professional component of imaging services in the final rule published in
the Federal Register, v. 77, n. 222, November 16, 2012, pages 68891–69380
under the physician fee schedule under section 1848 of the Social Security
Act (42 U.S.C. 1395w–4).
221.
Medicaid DSH
(a)
Modifications of reductions to allotments
Section 1923(f) of the Social Security Act (42 U.S.C. 1396r–4(f)) is amended—
(1) in paragraph (7)(A)—
(A) in clause (i), by striking 2016 through 2020 and inserting 2017 through 2024; and
(B) in clause (ii), by striking subclauses (I) through (IV), and inserting the following:
(I) $1,800,000,000 for fiscal year 2017;
(II) $4,700,000,000 for fiscal year 2018;
(III) $4,700,000,000 for fiscal year 2019;
(IV) $4,700,000,000 for fiscal year 2020;
(V) $4,800,000,000 for fiscal year 2021;
(VI) $5,000,000,000 for fiscal year 2022;
(VII) $5,000,000,000 for fiscal year 2023; and
(VIII) $4,400,000,000 for fiscal year 2024.
; and
(2) by striking paragraph (8) and inserting the following:
(8)
Calculation of DSH allotments after reductions period
The DSH allotment for a State for fiscal years after fiscal year 2024 shall be calculated under
paragraph (3) without regard to paragraph (7).
.
(b)
MACPAC review and report
Section 1900(b)(6) of the Social Security Act (42 U.S.C. 1396(b)(6)) is amended—
(1) by striking MACPAC shall consult and inserting the following:
(A)
In general
MACPAC shall consult
; and
(2) by adding at the end the following:
(B)
Review and reports regarding Medicaid DSH
(i)
In general
MACPAC shall review and submit an annual report to Congress on disproportionate share hospital
payments under section 1923. Each report shall include the information
specified in clause (ii).
(ii)
Required report information
Each report required under this subparagraph shall include the following:
(I)
Data relating to changes in the number of uninsured individuals.
(II)
Data relating to the amount and sources of hospitals' uncompensated care costs, including the
amount of such costs that are the result of providing unreimbursed or
under-reimbursed services, charity care, or bad debt.
(III)
Data identifying hospitals with high levels of uncompensated care that also provide access to
essential community services for low-income, uninsured, and vulnerable
populations, such as graduate medical education, and the continuum of
primary through quarternary care, including the provision of trauma care
and public health services.
(IV) State-specific analyses regarding the relationship between the most recent State DSH allotment and
the projected State DSH allotment for the succeeding year and the data
reported under subclauses (I), (II), and (III) for the State.
(iii)
Data
Notwithstanding any other provision of law, the Secretary regularly shall provide MACPAC with the
most recent State reports and most recent independent certified audits
submitted under section 1923(j), cost reports submitted under title XVIII,
and such other data as MACPAC may request for purposes of conducting the
reviews and preparing and submitting the annual reports required under
this subparagraph.
(iv)
Submission deadlines
The first report required under this subparagraph shall be submitted to Congress not later than
February 1, 2016. Subsequent reports shall be submitted as part of, or
with, each annual report required under paragraph (1)(C) during the period
of fiscal years 2017 through 2024.
.
222.
Realignment of the Medicare sequester for fiscal year 2024
Paragraph (6) (relating to implementing direct spending reductions) of section 251A of the Balanced
Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 901a) is amended by adding at the end the following new subparagraph:
(D) Notwithstanding the 2 percent limit specified in subparagraph (A) for payments for the Medicare
programs specified in section 256(d), the sequestration order of the
President under such subparagraph for fiscal year 2024 shall be applied to
such payments so that—
(i) with respect to the first 6 months in which such order is effective for such fiscal year, the
payment reduction shall be 4.0 percent; and
(ii) with respect to the second 6 months in which such order is so effective for such fiscal year, the
payment reduction shall be 0.0 percent.
.
223.
Demonstration programs to improve community mental health services
(a)
Criteria for certified community behavioral health clinics To participate in demonstration programs
(1)
Publication
Not later than September 1, 2015, the Secretary shall publish criteria for a clinic to be certified
by a State as a certified community behavioral health clinic for purposes
of participating in a demonstration program conducted under subsection
(d).
(2)
Requirements
The criteria published under this subsection shall include criteria with respect to the following:
(A)
Staffing
Staffing requirements, including criteria that staff have diverse disciplinary backgrounds, have
necessary State-required license and accreditation, and are culturally and
linguistically trained to serve the needs of the clinic's patient
population.
(B)
Availability and accessibility of services
Availability and accessibility of services, including crisis management services that are available
and accessible 24 hours a day, the use of a sliding scale for payment, and
no rejection for services or limiting of services on the basis of a
patient's ability to pay or a place of residence.
(C)
Care coordination
Care coordination, including requirements to coordinate care across settings and providers to
ensure seamless transitions for patients across the full spectrum of
health services including acute, chronic, and behavioral health needs.
Care coordination requirements shall include partnerships or formal
contracts with the following:
(i) Federally-qualified health centers (and as applicable, rural health clinics) to provide
Federally-qualified health center services (and as applicable, rural
health clinic services) to the extent such services are not provided
directly through the certified community behavioral health clinic.
(ii) Inpatient psychiatric facilities and substance use detoxification, post-detoxification step-down
services, and residential programs.
(iii) Other community or regional services, supports, and providers, including schools, child welfare
agencies, juvenile and criminal justice agencies and facilities, Indian
Health Service youth regional treatment centers, State licensed and
nationally accredited child placing agencies for therapeutic foster care
service, and other social and human services.
(iv) Department of Veterans Affairs medical centers, independent outpatient clinics, drop-in centers,
and other facilities of the Department as defined in section 1801 of title 38, United States Code.
(v) Inpatient acute care hospitals and hospital outpatient clinics.
(D)
Scope of services
Provision (in a manner reflecting person-centered care) of the following services which, if not
available directly through the certified community behavioral health
clinic, are provided or referred through formal relationships with other
providers:
(i) Crisis mental health services, including 24-hour mobile crisis teams, emergency crisis intervention
services, and crisis stabilization.
(ii) Screening, assessment, and diagnosis, including risk assessment.
(iii) Patient-centered treatment planning or similar processes, including risk assessment and crisis
planning.
(iv) Outpatient mental health and substance use services.
(v) Outpatient clinic primary care screening and monitoring of key health indicators and health risk.
(vi) Targeted case management.
(vii) Psychiatric rehabilitation services.
(viii) Peer support and counselor services and family supports.
(ix) Intensive, community-based mental health care for members of the armed forces and veterans,
particularly those members and veterans located in rural areas, provided
the care is consistent with minimum clinical mental health guidelines
promulgated by the Veterans Health Administration including clinical
guidelines contained in the Uniform Mental Health Services Handbook of
such Administration.
(E)
Quality and other reporting
Reporting of encounter data, clinical outcomes data, quality data, and such other data as the
Secretary requires.
(F)
Organizational authority
Criteria that a clinic be a non-profit or part of a local government behavioral health authority or
operated under the authority of the Indian Health Service, an Indian tribe
or tribal organization pursuant to a contract, grant, cooperative
agreement, or compact with the Indian Health Service pursuant to the
Indian Self-Determination Act (25 U.S.C. 450 et seq.), or an urban Indian organization pursuant to a grant or contract with the Indian Health Service
under title V of the Indian Health Care Improvement Act (25 U.S.C. 1601 et seq.).
(b)
Guidance on development of prospective payment system for testing under demonstration programs
(1)
In general
Not later than September 1, 2015, the Secretary, through the Administrator of the Centers for
Medicare & Medicaid Services, shall issue guidance for the establishment of a prospective payment system that
shall only apply to medical assistance for mental health services
furnished by a certified community behavioral health clinic participating
in a demonstration program under subsection (d).
(2)
Requirements
The guidance issued by the Secretary under paragraph (1) shall provide that—
(A) no payment shall be made for inpatient care, residential treatment, room and board expenses, or any
other non-ambulatory services, as determined by the Secretary; and
(B) no payment shall be made to satellite facilities of certified community behavioral health clinics
if such facilities are established after the date of enactment of this
Act.
(c)
Planning grants
(1)
In general
Not later than January 1, 2016, the Secretary shall award planning grants to States for the purpose
of developing proposals to participate in time-limited demonstration
programs described in subsection (d).
(2)
Use of funds
A State awarded a planning grant under this subsection shall—
(A) solicit input with respect to the development of such a demonstration program from patients,
providers, and other stakeholders;
(B) certify clinics as certified community behavioral health clinics for purposes of participating in a
demonstration program conducted under subsection (d); and
(C) establish a prospective payment system for mental health services furnished by a certified
community behavioral health clinic participating in a demonstration
program under subsection (d) in accordance with the guidance issued under
subsection (b).
(d)
Demonstration programs
(1)
In general
Not later than September 1, 2017, the Secretary shall select States to participate in demonstration
programs that are developed through planning grants awarded under
subsection (c), meet the requirements of this subsection, and represent a
diverse selection of geographic areas, including rural and underserved
areas.
(2)
Application requirements
(A)
In general
The Secretary shall solicit applications to participate in demonstration programs under this
subsection solely from States awarded planning grants under subsection
(c).
(B)
Required information
An application for a demonstration program under this subsection shall include the following:
(i) The target Medicaid population to be served under the demonstration program.
(ii) A list of participating certified community behavioral health clinics.
(iii) Verification that the State has certified a participating clinic as a certified community
behavioral health clinic in accordance with the requirements of subsection
(b).
(iv) A description of the scope of the mental health services available under the State Medicaid program
that will be paid for under the prospective payment system tested in the
demonstration program.
(v) Verification that the State has agreed to pay for such services at the rate established under the
prospective payment system.
(vi) Such other information as the Secretary may require relating to the demonstration program including
with respect to determining the soundness of the proposed prospective
payment system.
(3)
Number and length of demonstration programs
Not more than 8 States shall be selected for 2-year demonstration programs under this subsection.
(4)
Requirements for selecting demonstration programs
(A)
In general
The Secretary shall give preference to selecting demonstration programs where participating
certified community behavioral health clinics—
(i) provide the most complete scope of services described in subsection (a)(2)(D) to individuals
eligible for medical assistance under the State Medicaid program;
(ii) will improve availability of, access to, and participation in, services described in subsection
(a)(2)(D) to individuals eligible for medical assistance under the State
Medicaid program;
(iii) will improve availability of, access to, and participation in assisted outpatient mental health
treatment in the State; or
(iv) demonstrate the potential to expand available mental health services in a demonstration area and
increase the quality of such services without increasing net Federal
spending.
(5)
Payment for medical assistance for mental health services provided by certified community
behavioral health clinics
(A)
In general
The Secretary shall pay a State participating in a demonstration program under this subsection the
Federal matching percentage specified in subparagraph (B) for amounts
expended by the State to provide medical assistance for mental health
services described in the demonstration program application in accordance
with paragraph (2)(B)(iv) that are provided by certified community
behavioral health clinics to individuals who are enrolled in the State
Medicaid program. Payments to States made under this paragraph shall be
considered to have been under, and are subject to the requirements of,
section 1903 of the Social Security Act (42 U.S.C. 1396b).
(B)
Federal matching percentage
The Federal matching percentage specified in this subparagraph is with respect to medical
assistance described in subparagraph (A) that is furnished—
(i) to a newly eligible individual described in paragraph (2) of section 1905(y) of the Social Security
Act (42 U.S.C. 1396d(y)), the matching rate applicable under paragraph (1) of that section; and
(ii) to an individual who is not a newly eligible individual (as so described) but who is eligible for
medical assistance under the State Medicaid program, the enhanced FMAP
applicable to the State.
(C)
Limitations
(i)
In general
Payments shall be made under this paragraph to a State only for mental health services—
(I) that are described in the demonstration program application in accordance with paragraph (2)(iv);
(II) for which payment is available under the State Medicaid program; and
(III) that are provided to an individual who is eligible for medical assistance under the State Medicaid
program.
(ii)
Prohibited payments
No payment shall be made under this paragraph—
(I) for inpatient care, residential treatment, room and board expenses, or any other non-ambulatory
services, as determined by the Secretary; or
(II) with respect to payments made to satellite facilities of certified community behavioral health
clinics if such facilities are established after the date of enactment of
this Act.
(6)
Waiver of statewideness requirement
The Secretary shall waive section 1902(a)(1) of the Social Security Act (42 U.S.C. 1396a(a)(1)) (relating to statewideness) as may be necessary to conduct demonstration programs in accordance
with the requirements of this subsection.
(7)
Annual reports
(A)
In general
Not later than 1 year after the date on which the first State is selected for a demonstration
program under this subsection, and annually thereafter, the Secretary
shall submit to Congress an annual report on the use of funds provided
under all demonstration programs conducted under this subsection. Each
such report shall include—
(i) an assessment of access to community-based mental health services under the Medicaid program in the
area or areas of a State targeted by a demonstration program compared to
other areas of the State;
(ii) an assessment of the quality and scope of services provided by certified community behavioral
health clinics compared to community-based mental health services provided
in States not participating in a demonstration program under this
subsection and in areas of a demonstration State that are not
participating in the demonstration program; and
(iii) an assessment of the impact of the demonstration programs on the Federal and State costs of a full
range of mental health services (including inpatient, emergency and
ambulatory services).
(B)
Recommendations
Not later than December 31, 2021, the Secretary shall submit to Congress recommendations concerning
whether the demonstration programs under this section should be continued,
expanded, modified, or terminated.
(e)
Definitions
In this section:
(1)
Federally-qualified health center services; Federally-qualified health center; rural health clinic
services; rural health clinic
The terms Federally-qualified health center services, Federally-qualified health center, rural health clinic services, and rural health clinic have the meanings given those terms in section 1905(l) of the Social Security Act (42 U.S.C. 1396d(l)).
(2)
Enhanced FMAP
The term enhanced FMAP has the meaning given that term in section 2105(b) of the Social Security Act (42 U.S.C. 1397dd(b)) but without regard to the second and third sentences of that section.
(3)
Secretary
The term Secretary means the Secretary of Health and Human Services.
(4)
State
The term State has the meaning given such term for purposes of title XIX of the Social Security Act (42 U.S.C. 1396 et seq.).
(f)
Funding
(1)
In general
Out of any funds in the Treasury not otherwise appropriated, there is appropriated to the
Secretary—
(A) for purposes of carrying out subsections (a), (b), and (d)(7), $2,000,000 for fiscal year 2014; and
(B) for purposes of awarding planning grants under subsection (c), $25,000,000 for fiscal year 2016.
(2)
Availability
Funds appropriated under paragraph (1) shall remain available until expended.
224.
Assisted outpatient treatment grant program for individuals with serious mental illness
(a)
In general
The Secretary shall establish a 4-year pilot program to award not more than 50 grants each year to
eligible entities for assisted outpatient treatment programs for
individuals with serious mental illness.
(b)
Consultation
The Secretary shall carry out this section in consultation with the Director of the National
Institute of Mental Health, the Attorney General of the United States, the
Administrator of the Administration for Community Living, and the
Administrator of the Substance Abuse and Mental Health Services
Administration.
(c)
Selecting among applicants
The Secretary—
(1) may only award grants under this section to applicants that have not previously implemented an
assisted outpatient treatment program; and
(2) shall evaluate applicants based on their potential to reduce hospitalization, homelessness,
incarceration, and interaction with the criminal justice system while
improving the health and social outcomes of the patient.
(d)
Use of grant
An assisted outpatient treatment program funded with a grant awarded under this section shall
include—
(1) evaluating the medical and social needs of the patients who are participating in the program;
(2) preparing and executing treatment plans for such patients that—
(A) include criteria for completion of court-ordered treatment; and
(B) provide for monitoring of the patient’s compliance with the treatment plan, including compliance
with medication and other treatment regimens;
(3) providing for such patients case management services that support the treatment plan;
(4) ensuring appropriate referrals to medical and social service providers;
(5) evaluating the process for implementing the program to ensure consistency with the patient’s needs
and State law; and
(6) measuring treatment outcomes, including health and social outcomes such as rates of incarceration,
health care utilization, and homelessness.
(e)
Report
Not later than the end of each of fiscal years 2016, 2017, and 2018, the Secretary shall submit a
report to the appropriate congressional committees on the grant program
under this section. Each such report shall include an evaluation of the
following:
(1) Cost savings and public health outcomes such as mortality, suicide, substance abuse,
hospitalization, and use of services.
(2) Rates of incarceration by patients.
(3) Rates of homelessness among patients.
(4) Patient and family satisfaction with program participation.
(f)
Definitions
In this section:
(1) The term assisted outpatient treatment means medically prescribed mental health treatment that a patient receives while living in a
community under the terms of a law authorizing a State or local court to
order such treatment.
(2) The term eligible entity means a county, city, mental health system, mental health court, or any other entity with
authority under the law of the State in which the grantee is located to
implement, monitor, and oversee assisted outpatient treatment programs.
(3) The term Secretary means the Secretary of Health and Human Services.
(g)
Funding
(1)
Amount of grants
A grant under this section shall be in an amount that is not more than $1,000,000 for each of
fiscal years 2015 through 2018. Subject to the preceding sentence, the
Secretary shall determine the amount of each grant based on the population
of the area, including estimated patients, to be served under the grant.
(2)
Authorization of appropriations
There is authorized to be appropriated to carry out this section $15,000,000 for each of fiscal
years 2015 through 2018.
225.
Exclusion from PAYGO scorecards
(a)
Statutory Pay-As-You-Go scorecards
The budgetary effects of this Act shall not be entered on either PAYGO scorecard maintained
pursuant to section 4(d) of the Statutory Pay-As-You-Go Act of 2010.
(b)
Senate PAYGO scorecards
The budgetary effects of this Act shall not be entered on any PAYGO scorecard maintained for
purposes of section 201 of S. Con. Res. 21 (110th Congress).
Passed the House of Representatives March 27, 2014.Karen L. Haas,Clerk